financetom
Business
financetom
/
Business
/
Factbox-Who are OpenAI's new board members?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Factbox-Who are OpenAI's new board members?
Mar 11, 2024 8:13 AM

(Reuters) - Sam Altman is rejoining the board of ChatGPT-maker OpenAI along with three new directors, as the startup tries to move past his sudden ouster in November that had shocked the tech industry.

Altman had returned as CEO of OpenAI just four days after his firing with a new board made up of Quora CEO Adam D'Angelo, former U.S. Treasury Secretary Larry Summers and former co-CEO of Salesforce Bret Taylor.

The board will now expand with the addition of Sue Desmond-Hellmann, former CEO of the Bill and Melinda Gates Foundation, Nicole Seligman, former president of Sony Entertainment, and Instacart CEO Fidji Simo.

Here are more details about the new members:

FIDJI SIMO

Simo serves as chief executive and chair of Instacart. She also sits on the board of Shopify ( SHOP ).

She spent a decade at social media giant Meta Platforms ( META ), including as the head of Facebook from 2019 until 2021.

She also serves as president of the Metrodora Foundation. Simo is a co-founder of the Metrodora Institute, a multidisciplinary medical clinic and research foundation, which she co-founded.

SUE DESMOND-HELLMAN

A former board member of Meta, Desmond-Hellman was the CEO of the Bill and Melinda Gates Foundation from 2014-20. She is also a former director of Proctor and Gamble's board and currently serves on the board of U.S. drugmaker Pfizer ( PFE ) and the President's Council of Advisors on Science and Technology.

She was professor and chancellor of the University of California, San Francisco from 2009 to 2014, the first woman to hold the position. She has also served as president of product development at biotechnology firm Genentech.

NICOLE SELIGMAN

The lawyer is a board member at Paramount Global, MeiraGTx ( MGTX ) and Intuitive Machines. She also served on the board of Viacom through 2019, when it merged with CBS to form Paramount, then called ViacomCBS.

She has held several leadership positions at Japanese company Sony ( SONY ) including president of Sony Entertainment from 2014-16 and president of Sony's ( SONY ) America business.

She was a partner in litigation practise at American law firm Williams & Connolly LLP. She also served as a law clerk to Justice Thurgood Marshall on the Supreme Court of the United States.

(Reporting by Jaspreet Singh and Arsheeya Bajwa in Bengaluru; Editing by Anil D'Silva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
iLearningEngines Begins Chapter 11 Bankruptcy Proceedings
iLearningEngines Begins Chapter 11 Bankruptcy Proceedings
Dec 23, 2024
08:32 AM EST, 12/23/2024 (MT Newswires) -- iLearningEngines (AILE) said Monday it has started voluntary Chapter 11 bankruptcy proceedings. The company said it intends to continue offering support to its installed client base and will seek court approval to operate the business during the proceedings, which were initiated Friday. Shares of the company fell more than 35% in recent Monday...
Saputo Chief Operating Officer Frank Guido Steps Down
Saputo Chief Operating Officer Frank Guido Steps Down
Dec 23, 2024
08:35 AM EST, 12/23/2024 (MT Newswires) -- Saputo ( SAPIF ) on Monday said Frank Guido stepped down from his role as chief operating officer for personal reasons, effective immediately. The dairy processing company said Carl Colizza, president and chief executive, will assume the additional duties of COO in the interim. ...
Arrowhead Pharmaceuticals Doses First Patients in Trial of Potential Obesity Drug
Arrowhead Pharmaceuticals Doses First Patients in Trial of Potential Obesity Drug
Dec 23, 2024
08:36 AM EST, 12/23/2024 (MT Newswires) -- Arrowhead Pharmaceuticals ( ARWR ) said Monday it dosed the first patients in a phase 1/2a clinical trial of ARO-INHBE, the company's investigational therapy to counter obesity. The study will treat patients with ARO-INHBE as monotherapy in part 1 and in combination with tirzepatide in part 2. The company also recently filed for...
RAPT Therapeutics, Shanghai Jemincare Sign Exclusive License Deal for Potential Food Allergy Treatment; Shares Up Pre-Bell
RAPT Therapeutics, Shanghai Jemincare Sign Exclusive License Deal for Potential Food Allergy Treatment; Shares Up Pre-Bell
Dec 23, 2024
08:33 AM EST, 12/23/2024 (MT Newswires) -- RAPT Therapeutics ( RAPT ) shares were up 89% premarket Monday after the company and Shanghai Jemincare said Monday they have signed an exclusive license agreement for JYB1904, a clinical-stage anti-immunoglobulin E monoclonal antibody. The deal gives RAPT rights to develop and commercialize JYB1904, which has an RAPT designation of RPT904, globally except...
Copyright 2023-2026 - www.financetom.com All Rights Reserved